1. Differential Expression and Mutation of therasFamily Genes in Human Breast Cancer
   Spiros Miyakis et al, 1998, Biochemical and Biophysical Research Communications CrossRef
2. Ras activation in human breast cancer
   Friederike C. von Lintig et al, 2000, Breast Cancer Research and Treatment CrossRef
3. Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing Melanoma
   Andrew J. Haak et al, 2017, Molecular Cancer Therapeutics CrossRef
4. Restriction Endonuclease-Mediated Selective Polymerase Chain Reaction
   Robyn Ward et al, 1998, The American Journal of Pathology CrossRef
5. Clinical implications of routine genomic mutation sequencing in PIK3CA/AKT1 and KRAS/NRAS/BRAF in metastatic breast cancer
   Juan Miguel Cejalvo et al, 2016, Breast Cancer Research and Treatment CrossRef
6. Perspective Chapter: Evaluating New Drugs against K-Ras4B/PDE6δ Using an In Vitro Approach
   Dayan A. Carrion-Estrada et al, 2024, Technologies in Cell Culture - A Journey From Basics to Advanced Applications CrossRef
7. Deregulated miRNAs in Hereditary Breast Cancer Revealed a Role for miR-30c in Regulating KRAS Oncogene
   Miljana Tanic et al, 2012, PLoS ONE CrossRef
8. Down-regulation of K-ras and H-ras in human brain gliomas
   Rena Lymbouridou et al, 2009, European Journal of Cancer CrossRef
9. Detection of point mutations at codon 12 of KI-ras in ophthalmic pterygia
   E T Detorakis et al, 2005, Eye CrossRef